Jeffrey Bernstein

Jeffrey Bernstein is the current President & CEO at Elorac. Jeffrey has previously held the position of Senior Vice President, Chief Operating Officer at Winston Laboratories from August 2005 to September 2007. In this role, they were responsible for directing day-to-day operations at a specialty pharmaceutical company developing novel prescription pain medications. Jeffrey also assumed additional administrative and managerial responsibilities while continuing as acting CFO.

From December 2002 to August 2005, they were the Vice President, Chief Financial Officer at Winston Laboratories where they managed all accounting functions and represented the company in its relations with financial institutions, benefit providers, and outside counsel. Jeffrey also led the divestment of non-core businesses and maintained P&L responsibility for a subsidiary that marketed over-the-counter (OTC) pain medications.

Under Jeffrey Bernstein's leadership, Elorac has seen significant growth and success. Jeffrey has proven himself to be an effective leader and manager with a strong financial background. Their experience will continue to be a valuable asset to Elorac as it looks to grow and expand its operations in the future.

Jeffrey Bernstein received their Ph.D. in Business Economics from Harvard University. Jeffrey also holds an AM in Business Economics from Harvard University and a 1991 degree in Economics from Amherst College. In addition, they are certified as a Chartered Financial Analyst (CFA) from the CFA Institute.

and Scott B. Phillips - SVP, Scientific Affairs reports to Jeffrey Bernstein.